BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14572203)

  • 21. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
    Tomita T; Homma M; Yuzawa K; Ohkohchi N; Hori T; Kaneko M; Hasegawa Y; Kojima H; Nagasawa T; Kohda Y
    Ther Drug Monit; 2005 Feb; 27(1):94-7. PubMed ID: 15665753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
    Cogill JL; Taylor PJ; Westley IS; Morris RG; Lynch SV; Johnson AG
    Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoassay determination of rapamycin: reliability of the method with respect to liquid chromatography mass spectrometric quantification.
    Pieri M; Capone D; Gentile A; Miraglia N; Leo E; Federico S; Basile V; Acampora A
    Clin Transplant; 2007; 21(5):633-7. PubMed ID: 17845638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
    Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
    Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.
    Colantonio DA; Borden KK; Clarke W
    Clin Biochem; 2007 Jun; 40(9-10):680-7. PubMed ID: 17428457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
    Moscato D; Nonnato A; Adamo R; Vancheri M; Caropreso A
    Clin Chim Acta; 2010 Jan; 411(1-2):77-80. PubMed ID: 19835852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
    Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
    Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay.
    Tomita T; Homma M; Hasegawa Y; Kojima H; Ohkohchi N; Hori T; Kaneko M; Nakano Y; Tobe T; Kohda Y
    Biol Pharm Bull; 2008 Jun; 31(6):1250-3. PubMed ID: 18520063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L; Cointault O; Marquet P; Josse AG; Lavit M; Saint-Marcoux F; Kamar N
    Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
    Hermida-Cadahia EF; Tutor JC
    Scand J Clin Lab Invest; 2012 Apr; 72(2):180-3. PubMed ID: 22248047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of factors influencing tacrolimus levels and immunoassay bias in renal transplantation.
    Borrows R; Chusney G; Loucaidou M; James A; Goel S; Borrows S; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    J Clin Pharmacol; 2007 Aug; 47(8):1035-42. PubMed ID: 17660485
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunoassay for the measurement of sirolimus.
    Jones K; Saadat-Lajevard S; Lee T; Horwatt R; Hicks D; Johnston A; Holt DW
    Clin Ther; 2000; 22 Suppl B():B49-61. PubMed ID: 10823373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation.
    Joo DJ; Jung I; Kim MS; Huh KH; Kim H; Choi JS; Choi GH; Kim SI
    Transplant Proc; 2010 Dec; 42(10):4137-40. PubMed ID: 21168645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry.
    Webb NJ; Roberts D; Preziosi R; Keevil BG
    Pediatr Transplant; 2005 Dec; 9(6):729-33. PubMed ID: 16269043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.